Daria Mochly-Rosen
Jump to navigation
Jump to search
Daria Mochly-Rosen is a Professor of Chemical and Systems Biology at the Stanford University School of Medicine, where she also holds the George D. Smith Chair for Translational Medicine.[1] She is in addition the founder of Mitoconix Bio, a startup company whose goal is to produce drugs that treat Huntington's disease and other neurodegenerative illnesses.[2][3][4]
References
- ^ "Daria Mochly-Rosen". Stanford University. Retrieved 2018-08-12.
- ^ "Neurological therapy co Mitoconix Bio raises $20m". Globes. Retrieved 2017-06-27.
- ^ "California Life Sciences Association (CLSA) Adds Leaders from City of Hope, Stanford to Board of Directors". Retrieved 2017-02-13.[permanent dead link]
- ^ Danney, Micah (2017-07-05). "Israeli startup takes aim at Huntington's disease". The Times of Israel. Retrieved 2018-08-12.
External links
- Daria Mochly-Rosen publications indexed by Google Scholar
Categories:
- All articles with dead external links
- Articles with dead external links from January 2024
- Articles with permanently dead external links
- Articles with short description
- Short description is different from Wikidata
- Articles with ISNI identifiers
- Articles with VIAF identifiers
- Articles with J9U identifiers
- Articles with LCCN identifiers
- Articles with NKC identifiers
- Articles with Google Scholar identifiers
- Articles with ORCID identifiers
- American women biologists
- Living people
- Stanford University School of Medicine faculty
- Year of birth missing (living people)
- 21st-century American women
- All stub articles
- Biologist stubs